Back to Top
Capromab Biosimilar - Research Grade
$710.00 - $6,900.00
Capromab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
FOLH1ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
Q04609
Shipping Conditions
Blue ice
Background
Folate hydrolase 1 (FOLH1/PSMA) is a prostate-restricted membrane antigen that is highly upregulated in prostate cancer, making it a prominent oncology and imaging target. As an unconjugated, non-therapeutic analog of capromab, this human IgG1-kappa recombinant antibody is supplied for research use only (RUO). It is formulated low in endotoxin to in vivo standards and manufactured in scalable milligram-to-gram quantities for bulk and high-throughput laboratories. Researchers use it in functional and binding assays, antigen-targeting and internalization studies, in vitro screening and preclinical prostate-cancer models exploring PSMA.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













